Modulation by Polymyxin-B Hemoperfusion of Inflammatory Response Related to Severe Peritonitis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Shock

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SHK.0000000000000725PMID 27984535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-22: immunobiology and pathology.

  2015cited by this paper
• Cytokine profile in severe gram-positive and gram-negative abdominal sepsis

  2015cited by this paper
• Elevated Serum PCT in Septic Shock With Endotoxemia Is Associated With a Higher Mortality Rate

  2015cited by this paper
• Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial

  2015cited by this paper
• Effect of interleukin-17 on in vitro cytokine production in healthy controls and patients with severe sepsis.

  2015cited by this paper
• Polymyxin B hemoperfusion: a mechanistic perspective

  2014cited by this paper
• Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines.

  2014cited by this paper
• Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis.

  2013cited by this paper
• RETRACTED: Peritonitis from Perforated Peptic Ulcer and Immune Response

  2013cited by this paper
• Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

  2013cited by this paper
• Therapeutic potential of targeting IL-17 and IL-23 in sepsis

  2012cited by this paper
• Evidence for anti‐inflammatory effects of C5a on the innate IL‐17A/IL‐23 axis

  2012cited by this paper
• Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.

  2011cited by this paper
• Endotoxin removal devices for the treatment of sepsis and septic shock.

  2011cited by this paper
• INTERLEUKIN-22 DETECTED IN PATIENTS WITH ABDOMINAL SEPSIS

  2010cited by this paper
• Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial

  2010influential reference
• Endotoxin elimination in sepsis: physiology and therapeutic application

  2010cited by this paper
• Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis.

  2010cited by this paper
• Direct hemoperfusion with polymyxin-B-immobilized fiber columns improves septic hypotension and reduces inflammatory mediators in septic patients with colorectal perforation

  2009cited by this paper
• Factors associated with septic shock and mortality in generalized peritonitis: comparison between community-acquired and postoperative peritonitis

  2009cited by this paper
• Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.

  2009cited by this paper
• Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: A randomized controlled trial*

  2009cited by this paper
• Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients.

  2008cited by this paper
• Adverse functions of IL‐17A in experimental sepsis

  2008cited by this paper
• Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors

  2008influential reference
• Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis

  2007cited by this paper
• Multi-Scale Analysis of the Toraymyxin Adsorption Cartridge Part I: Molecular Interaction of Polymyxin B with Endotoxins

  2006cited by this paper
• Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA.

  2006cited by this paper
• A PILOT-CONTROLLED STUDY OF A POLYMYXIN B-IMMOBILIZED HEMOPERFUSION CARTRIDGE IN PATIENTS WITH SEVERE SEPSIS SECONDARY TO INTRA-ABDOMINAL INFECTION

  2005influential reference
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• Extracorporeal Endotoxin Removal For The Treatment of Sepsis:Endotoxin Adsorption Cartridge (Toraymyxin)

  2003cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• Continuous hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure.

  2002influential reference
• Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture.

  2000cited by this paper
• Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis

  2000cited by this paper
• Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock.

  1999cited by this paper
• Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

  1993cited by this paper

• Comparing adsorptive blood purification modalities for sepsis patients: a systematic review and network meta-analysis.

  2025cites this paper
• Immunomodulation in Pediatric Sepsis: A Narrative Review

  2025cites this paper
• Effects on mortality of blood purification techniques in severe septic shock patients. An updated Bayesian network meta-analysis of randomized controlled trials.

  2025cites this paper
• The role of polymyxin B-immobilized hemoperfusion in reducing mortality and enhancing hemodynamics in patients with sepsis and septic shock: A systematic review and meta-analysis

  2024cites this paper
• Blood Purification for Adult Patients With Severe Infection or Sepsis/Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials

  2023cites this paper
• The Techniques of Blood Purification in the Treatment of Sepsis and Other Hyperinflammatory Conditions

  2023cites this paper
• HEMOPERFUSION USING THE LPS-SELECTIVE MESOPOROUS POLYMERIC ADSORBENT IN SEPTIC SHOCK: A MULTICENTER RANDOMIZED CLINICAL TRIAL

  2023cites this paper
• Endotoxin Mass Concentration in Plasma Is Associated With Mortality in a Multicentric Cohort of Peritonitis-Induced Shock

  2021cites this paper
• Up-to-date information on polymyxin B-immobilized fiber column direct hemoperfusion for septic shock

  2021cites this paper
• Continuous renal replacement therapy under special conditions like sepsis, burn, cardiac failure, neurotrauma, and liver failure

  2021influential citation
• ИСПОЛЬЗОВАНИЕ СЕЛЕКТИВНОЙ ГЕМОСОРБЦИИ ЛИПОПОЛИСАХАРИДОВ В КОМПЛЕКСНОМ ЛЕЧЕНИИ СЕПСИСА

  2020cites this paper
• Effect of Extracorporeal Blood Purification on Mortality in Sepsis: A Meta-Analysis and Trial Sequential Analysis

  2020cites this paper
• The Use of Selective Hemosorption of Lipopolysaccharides in the Complex Treatment of Sepsis

  2020cites this paper
• Haemoperfusion with polymyxin B membrane: Recent results for an old debate!

  2019cites this paper
• Integrated Endotoxin Adsorption and Antibacterial Properties of Cationic Polyurethane Foams for Wound Healing.

  2019cites this paper
• oXirisNet Registry: A Prospective, National Registry on the oXiris Membrane

  2019cites this paper
• Extracorporeal Cytokine Removal in Septic Shock

  2019cites this paper
• Cytokine removal in human septic shock: Where are we and where are we going?

  2019cites this paper
• Blood Purification Techniques for Sepsis and Septic AKI.

  2019cites this paper
• エンドトキシン吸着カラム（PMX-DHP）は有用か？

  2018cites this paper
• Sepsis and septic shock.

  2018cites this paper
• Blood Purification With CytoSorb in Critically Ill Patients: Single‐Center Preliminary Experience

  2018cites this paper
• An update on membranes and cartridges for extracorporeal blood purification in sepsis and septic shock

  2018cites this paper
• Impact of hemoperfusion with polymyxin B added to hemofiltration in patients with endotoxic shock: a case–control study

  2018cites this paper
• Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis

  2018cites this paper
• What’s new in the extracorporeal treatment of sepsis?

  2017cites this paper
• What's New in Shock, January 2017?

  2016cites this paper